The two pharmaceutical companies that make Hep C medications have programs to help people complete treatment.

Hoffman-La Roche has the PegAssist program for people taking peg-interferon alpha-2a (known as Pegasys).

Merck has the Peg-Care program for people taking peg-interferon alpha-2b (known as Pegetron). 

Both programs support  people to access the funding necessary to cover treatment costs. These programs can inform patients about local, provincial, and federal government programs for accessing treatment and can help the patient find out ways to maximize any public funding or private medical insurance (including the appeals process, if the patient also has a supportive doctor).

If a person is eligible, these programs can sometimes even help cover the insurance company co-pay fee, Trillium's deductible, and a number of other expenses, depending on a person's specific situation.